Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Ziagen introduced by Glaxo Wellcome as new HIV treatment option

Feb. 2, 1999

New AIDS vaccine expected to begin clinical trials later this year

Feb. 2, 1999

Pharmacia & Upjohn describes new triazinic compounds with multiple pharmacological effects

Feb. 2, 1999

Shaman reviews filing strategy for SP-303 following pre-NDA meeting with FDA

Jan. 28, 1999

Novel piperazine hydroxyethylamine HIV protease inhibitor shows promise in preclinical studies

Jan. 28, 1999

Excellent anti-HIV activity seen with once-daily emtricitabine in phase I/II study

Jan. 27, 1999

Trimeris to present preliminary phase II trial results of T-20

Jan. 26, 1999

Acupuncture and amitriptyline do not provide pain relief in HIV-related peripheral neuropathy

Jan. 26, 1999

Cellular immune responses elicited by HGP-30 AIDS vaccine in mice

Jan. 21, 1999

Immune Response receives USD 5 million payment from Agouron

Jan. 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...